Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: APLE stock price vs OCGN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OCGN's multiple
Needs OCGN P/E.
Implied fair value · at APLE's multiple
Needs EPS (TTM) is negative, APLE P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: APLE FY 2025 (ended Dec 31, 2025) · OCGN FY 2025 (ended Dec 31, 2025).
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
APPLE HOSPITALITY REIT, INC. · implied price per share
Bear
$4.78
Base
$5.63
Bull
$6.47
OCUGEN, INC. · implied price per share
Bear
-$0.05
Base
-$0.06
Bull
-$0.07
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.49x
-2.37x
Net debt / EBITDA
Leverage against operating earnings
4.21x
-0.15x
Cash and equivalents
Liquid reserves on the balance sheet
$8.52M
$19.47M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HOST HOTELS & RESORTS, INC.
APLE vs HST
Sunstone Hotel Investors, Inc.
APLE vs SHO
Service Properties Trust
APLE vs SVC
IOVANCE BIOTHERAPEUTICS, INC.
APLE vs IOVA
bluebird bio, Inc.
APLE vs BLUE
BioNTech SE
APLE vs BNTX
Moderna, Inc.
APLE vs MRNA
Legend Biotech Corp
APLE vs LEGN
Arcturus Therapeutics Holdings Inc.
APLE vs ARCT
$1.54B
$28.79M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
